Search Results

Viewing Page 8 of 22 | Showing Results 71 - 80 of 214

Tazemetostat in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Endometrial Cancer

 

Gary Goodman, MD
Swedish Cancer Institute

DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors

 

Gary Goodman, MD
Swedish Cancer Institute
Viewing Page 8 of 22 | Showing Results 71 - 80 of 214